Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
he got the 3rd one; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 71-year-old male patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (received 1st dose of vaccine on 23rd February 1999) and Havrix (received 2nd dose of vaccine on 12th October1999). On 01-OCT-2024, the patient received the 3rd dose of Havrix. On 01-OCT-2024, an unknown time after receiving Havrix, the patient experienced extra dose administered (Verbatim: he got the 3rd one). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JUN-2025 Pharmacist just need to check and saw if this patient needs another vaccination. Patient had 2 (doses) in 1999, an another one (dose) last year, was typically a 2-shot series. But patient got the 3rd one which led to extra dose administered. Pharmacist questioned that if he needs a 4th dose.